Immunovia AB (publ) (STO:IMMNOV)

Immunovia AB Revenue

Immunovia AB had revenue of 424.00K SEK in the quarter ending March 31, 2026, with 110.95% growth. This brings the company's revenue in the last twelve months to 975.00K, down -24.48% year-over-year. In the year 2025, Immunovia AB had annual revenue of 752.00K, down -55.61%.

• Revenue (ttm): 975.00K
• Revenue Growth: -24.48%
• P/S Ratio: 135.12
• Revenue / Employee: 54.12K
• Employees: 17
• Market Cap: 124.31M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	752.00K	-942.00K	-55.61%
Dec 31, 2024	1.69M	-108.00K	-5.99%
Dec 31, 2023	1.80M	598.00K	49.67%
Dec 31, 2022	1.20M	248.00K	25.94%
Dec 31, 2021	956.00K	-30.00K	-3.04%
Dec 31, 2020	986.00K	172.00K	21.13%
Dec 31, 2019	814.00K	-263.00K	-24.42%
Dec 31, 2018	1.08M	-23.17M	-95.56%
Dec 31, 2017	24.25M	-254.10K	-1.04%
Dec 31, 2016	24.50M	7.50M	44.07%
Dec 31, 2015	17.01M	16.47M	3,084.89%
Dec 31, 2014	534.00K	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error